Skip to content

A study on the application of s-ketamine in modified electroconvulsive therapy for depression

A study on the application of s-ketamine in modified electroconvulsive therapy for depression

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039639
Enrollment
Unknown
Registered
2020-11-04
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

Experimental group:Before anesthesia, routine mask was used to denitrogen oxygen, 0.5mg/kg atropine was given, and then 0.5mg/kg S-ketamine and 1mg/kg succinylcholine were induced by anesthesia
Control group:Before anesthesia, routine mask was used to denitrogen oxygen, 0.5mg/kg atropine was given, and then 2mg/kg propofol and 1mg/kg succinylcholine were induced by anesthesia

Sponsors

Tongji Hospital Affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Make clear the object of MDD diagnosis (accord with tcd-10. Diagnosis of depressive episode (F32) or recurrent depression (f33)); 2. People aged 18-65, regardless of gender; 3. ASA grade: I ~ II; 4. Subjects with primary school education or above or who understand the content of the scale; 5. Obtain the informed consent of the patient and / or the legal guardian and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe physical diseases, such as cardiovascular and cerebrovascular diseases, intracranial hypertension, respiratory diseases and severe fractures, as well as patients with poorly controlled or untreated hypertension (systolic / diastolic blood pressure more than 180 / 100mmhg), glaucoma, aneurysm, or cerebral vascular malformation; 2. Patients with foreign body: pacemaker, intracranial electrode, etc.; 3. Patients with history of epilepsy; 4. Previous history of anesthesia allergy; 5. Pregnant and lactating women; 6. Patients with bipolar disorder or other mental diseases or mental retardation; 7. Patients with a history of drug abuse or dependence; 8. Subjects with hearing and speech communication disorder; 9. Other reasons why the researchers think it is not suitable to participate in the study.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale(HAMD);

Secondary

MeasureTime frame
QIDS-SR16;EEG;fMRI;BDNF;

Countries

China

Contacts

Public ContactXiaoqing Zhang

Tongji Hospital Affiliated to Tongji University

xq_820175@163.com+86 13501669460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026